Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04774770

HED-Start: Evaluating a Positive Skills Intervention for Patients New on Haemodialysis

HED-Start: A Randomised Controlled Trial to Evaluate a Positive Skills Intervention for Patients New on Haemodialysis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
148 (estimated)
Sponsor
Nanyang Technological University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Hemodialysis patients often experience barriers and misperceptions that hinder adjustment to life on dialysis. This study seeks to explore a group-based intervention (titled HED-Start) developed to improve self-care and emotional wellbeing among incident hemodialysis patients.

Detailed description

There are potentially modifiable psychosocial barriers and misperceptions about life on dialysis that hinder adjustment outcomes. It is hypothesized that these may include: poor understanding on what is needed or 'how to implement treatment principles', misperceptions related to disease and treatment, catastrophizing beliefs about impact of dialysis and low level of confidence on ability to manage treatment regime and renegotiate life roles as a "dialysis patient". This study seeks to explore the feasibility and acceptability of implementing a two-arm parallel randomized controlled trial of a group-based intervention (titled HED-Start). HED-Start is specifically developed to reduce psychological distress and support self-care and self-management outcomes in incident hemodialysis patients. Drawing on self-management and motivational interviewing principles paradigm, the HED-Start program aims to facilitate acquisition of skills and knowledge to support and improve self-care and emotional adjustment outcomes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHED-StartThe HED-Start Program is a cognitive-behavioral intervention based on self-management and motivational interviewing principles.

Timeline

Start date
2021-01-05
Primary completion
2022-10-07
Completion
2024-06-30
First posted
2021-03-01
Last updated
2024-04-15

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT04774770. Inclusion in this directory is not an endorsement.